Australia has introduced mandatory Unique Device Identification (UDI) requirements for medical devices, marking one of the most significant regulatory changes in recent years. The new UDI framework strengthens device traceability, improves post‑market surveillance, and aligns Australia with global systems such as the FDA GUDID and EU MDR/IVDR UDI frameworks.

This guide explains the new TGA UDI requirements, compliance timelines, affected device categories, and the practical steps manufacturers and sponsors must take to prepare.

What Is UDI and Why It Matters

UDI is a globally recognised system that assigns a unique identifier to each medical device model and its production details. The TGA states that UDI will:

• Improve device traceability across the supply chain
• Support faster identification and recall of affected devices
• Enhance clinical decision‑making and inventory management
• Provide structured data for regulators, hospitals, and procurement systems

UDI is now a core requirement for regulatory compliance in Australia.

Devices That Must Comply With UDI (All Classes)

Australia’s UDI requirements apply to all medical devices and all IVDs, regardless of risk class. Compliance is phased between 2026 and 2030, but every device supplied in Australia will eventually require:

• A UDI‑DI (device identifier)
• A UDI‑PI (production identifier)
• A UDI carrier (barcode, DataMatrix, or digital marking)
• A complete AusUDID record

Below is the complete list of device categories that must comply.

Medical Devices (Non‑IVD)

High‑Risk Devices (Mandatory from 1 July 2026)

• Class III medical devices
• Class IIb medical devices
• Implantable medical devices (all classes, including IIa implants)

Medium‑Risk Devices

• Class IIa medical devices (Mandatory between 2027–2029)

Low‑Risk Devices

• Class I medical devices (Mandatory by 2030)

Accessories

• Accessories to medical devices (Classified according to the parent device; all must comply)

Software & Digital Health Technologies

SaMD must comply with UDI, including digital UDI carrier placement within the software interface.

In Vitro Diagnostic Devices (IVDs)

All IVDs must comply with UDI requirements, including AusUDID data submission and updated labelling.

Custom‑Made Devices

Custom‑made devices must comply with UDI data requirements, although physical labelling obligations may differ depending on device type.

Reprocessed Single‑Use Devices

Reprocessed SUDs must carry a UDI that identifies:

• The original device
• The reprocessor
• The reprocessing cycle or batch

Australia’s UDI Compliance Timeline (2026–2030)

Mandatory Phase 1 — High‑Risk Devices (From 1 July 2026)

Mandatory for:

• Class III
• Class IIb
• Implantable devices

Requirements include UDI carrier placement and AusUDID data submission.

Mandatory Phase 2–4 (2027–2030)

Remaining devices transition in stages until 30 June 2030, including:

• Class IIa
• Class I
• All IVDs
• SaMD and AI‑based devices

Key Challenges for UDI Implementation

1. Labelling and Packaging Updates

Manufacturers must redesign labels and packaging to include UDI carriers (e.g., GS1 DataMatrix).

2. Data Quality and System Integration

UDI requires structured, validated data across ERP, PLM, and labelling systems.

3. AusUDID Submission Processes

Sponsors must establish reliable processes for creating, validating, and updating UDI records.

4. Supply Chain Readiness

Distributors, hospitals, and procurement systems must be able to scan and interpret UDI carriers.

5. Legacy Device Management

Existing devices may require transitional arrangements or re‑labelling.

How Manufacturers and Sponsors Can Prepare for UDI

1. Conduct a UDI Readiness Assessment

Identify which devices require UDI and map them against compliance deadlines.

2. Engage With Issuing Agencies

GS1 is the primary issuing agency for UDI in Australia. Ensure GTIN and barcode structures are correct.

3. Update ISO 13485 Quality Management System

QMS documentation must include:

• UDI generation
• Labelling controls
• Data management
• Change control
• Post‑market updates

4. Build AusUDID Submission Capability

Prepare internal processes for:

• Data validation
• Record creation
• Lifecycle updates
• Version control

5. Use the Voluntary Phase Strategically

Early submission reduces risk and allows time to refine systems before mandatory deadlines.

What UDI Means for Australian Medical Device Compliance

UDI is more than a labelling change — it is a full‑system transformation affecting:

• Regulatory compliance
• Supply chain operations
• Device lifecycle management
• Post‑market surveillance
• Hospital procurement and inventory systems

Early preparation is essential for avoiding disruption and maintaining market access.

Summary: What Sponsors and Manufacturers Must Do Now

• Confirm device classifications
• Update labelling and packaging
• Prepare UDI data structures
• Configure ERP/PLM systems
• Establish AusUDID submission processes
• Update ISO 13485 documentation
• Train staff across regulatory, quality, IT, and supply chain
• Begin voluntary submissions before July 2026

Australia’s UDI framework is now in force, and high‑risk devices must comply from 1 July 2026. Organisations that prepare early will minimise compliance risk and ensure smooth transition into the new regulatory environment.

Need some help?  Get started with our FREE UDI Checklist.

We are always here to help. Contact Us for guidnace and a free confidential discussion.